These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 9732400)

  • 1. Potentiation of CD95L-induced apoptosis of human malignant glioma cells by topotecan involves inhibition of RNA synthesis but not changes in CD95 or CD95L protein expression.
    Winter S; Weller M
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1374-82. PubMed ID: 9732400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Boswellic acids and malignant glioma: induction of apoptosis but no modulation of drug sensitivity.
    Glaser T; Winter S; Groscurth P; Safayhi H; Sailer ER; Ammon HP; Schabet M; Weller M
    Br J Cancer; 1999 May; 80(5-6):756-65. PubMed ID: 10360653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The topoisomerase II inhibitor, genistein, induces G2/M arrest and apoptosis in human malignant glioma cell lines.
    Schmidt F; Knobbe CB; Frank B; Wolburg H; Weller M
    Oncol Rep; 2008 Apr; 19(4):1061-6. PubMed ID: 18357397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dexamethasone-mediated protection from drug cytotoxicity: association with p21WAF1/CIP1 protein accumulation?
    Naumann U; Durka S; Weller M
    Oncogene; 1998 Sep; 17(12):1567-75. PubMed ID: 9794234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCNU-dependent potentiation of TRAIL/Apo2L-induced apoptosis in human glioma cells is p53-independent but may involve enhanced cytochrome c release.
    Röhn TA; Wagenknecht B; Roth W; Naumann U; Gulbins E; Krammer PH; Walczak H; Weller M
    Oncogene; 2001 Jul; 20(31):4128-37. PubMed ID: 11464279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The CD95/CD95 ligand system is not the major effector in anticancer drug-mediated apoptosis.
    Tolomeo M; Dusonchet L; Meli M; Grimaudo S; D'Alessandro N; Papoff G; Ruberti G; Rausa L
    Cell Death Differ; 1998 Sep; 5(9):735-42. PubMed ID: 10200532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of p21 as a target of cycloheximide-mediated facilitation of CD95-mediated apoptosis in human malignant glioma cells.
    Glaser T; Wagenknecht B; Weller M
    Oncogene; 2001 Aug; 20(35):4757-67. PubMed ID: 11521188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crm-A, bcl-2 and NDGA inhibit CD95L-induced apoptosis of malignant glioma cells at the level of caspase 8 processing.
    Wagenknecht B; Schulz JB; Gulbins E; Weller M
    Cell Death Differ; 1998 Oct; 5(10):894-900. PubMed ID: 10203695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chimeric tumor suppressor 1, a p53-derived chimeric tumor suppressor gene, kills p53 mutant and p53 wild-type glioma cells in synergy with irradiation and CD95 ligand.
    Naumann U; Kügler S; Wolburg H; Wick W; Rascher G; Schulz JB; Conseiller E; Bähr M; Weller M
    Cancer Res; 2001 Aug; 61(15):5833-42. PubMed ID: 11479223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Irradiation induced clonogenic cell death of human malignant glioma cells does not require CD95/CD95L interactions.
    Streffer JR; Schuster M; Pohl U; Belka C; Dichgans J; Bamberg M; Weller M
    Anticancer Res; 1999; 19(6B):5265-9. PubMed ID: 10697547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Death ligand/receptor-independent caspase activation mediates drug-induced cytotoxic cell death in human malignant glioma cells.
    Glaser T; Wagenknecht B; Groscurth P; Krammer PH; Weller M
    Oncogene; 1999 Sep; 18(36):5044-53. PubMed ID: 10490841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NF-kappaB-independent actions of sulfasalazine dissociate the CD95L- and Apo2L/TRAIL-dependent death signaling pathways in human malignant glioma cells.
    Hermisson M; Weller M
    Cell Death Differ; 2003 Sep; 10(9):1078-89. PubMed ID: 12934082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitization to CD95 ligand-induced apoptosis in human glioma cells by hyperthermia involves enhanced cytochrome c release.
    Hermisson M; Wagenknecht B; Wolburg H; Glaser T; Dichgans J; Weller M
    Oncogene; 2000 May; 19(19):2338-45. PubMed ID: 10822385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological effects of NO in malignant glioma cells: modulation by cytokines including CD95L and TGF-beta, dexamethasone, and p53 gene transfer.
    Rieger J; Ständer M; Löschmann PA; Heneka M; Dichgans J; Klockgether T; Weller M
    Oncogene; 1998 Nov; 17(18):2323-32. PubMed ID: 9811463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time-dependent changes in factors involved in the apoptotic process in human ovarian cancer cells as a response to cisplatin.
    Kolfschoten GM; Hulscher TM; Schrier SM; van Houten VM; Pinedo HM; Boven E
    Gynecol Oncol; 2002 Mar; 84(3):404-12. PubMed ID: 11855878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accumulation of mutant p53(V143A) modulates the growth, clonogenicity, and radiochemosensitivity of malignant glioma cells independent of endogenous p53 status.
    Bartussek C; Naumann U; Weller M
    Exp Cell Res; 1999 Dec; 253(2):432-9. PubMed ID: 10585266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C2-ceramide signaling in glioma cells: synergistic enhancement of CD95-mediated, caspase-dependent apoptosis.
    Wagenknecht B; Roth W; Gulbins E; Wolburg H; Weller M
    Cell Death Differ; 2001 Jun; 8(6):595-602. PubMed ID: 11536010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and biological activity of X-linked inhibitor of apoptosis (XIAP) in human malignant glioma.
    Wagenknecht B; Glaser T; Naumann U; Kügler S; Isenmann S; Bähr M; Korneluk R; Liston P; Weller M
    Cell Death Differ; 1999 Apr; 6(4):370-6. PubMed ID: 10381630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 enhances BAK and CD95 expression in human malignant glioma cells but does not enhance CD95L-induced apoptosis.
    Pohl U; Wagenknecht B; Naumann U; Weller M
    Cell Physiol Biochem; 1999; 9(1):29-37. PubMed ID: 10352342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Staurosporine-induced apoptosis is independent of p16 and p21 and achieved via arrest at G2/M and at G1 in U251MG human glioma cell line.
    Yamasaki F; Hama S; Yoshioka H; Kajiwara Y; Yahara K; Sugiyama K; Heike Y; Arita K; Kurisu K
    Cancer Chemother Pharmacol; 2003 Apr; 51(4):271-83. PubMed ID: 12721754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.